Reify Corporation

Reify corporation announces Myosight(tm)

Myosight captures data from dozens of cells at once, delivering unbiased results on how compounds affect typical and atypical heart cells. This technology enables researchers to see whether drugs carry a risk of causing arrhythmias or other adverse effects.

SourceReify Corporation·DateNov 14, 2005

Reify Corporation's Visible Discovery(tm) technology showcased at ICSB conference

Reify's Visible Discovery technology demonstrates high-throughput in vivo and in vitro phenotypic screens for cardiovascular structure and function, as well as subcellular particle movement. The platform provides fast, unbiased results with minimal end-user intervention.

SourceReify Corporation·DateOct 20, 2005